Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations (Q81251217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

title

Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

author name string

T Schweighoffer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

Pathology and Oncology Research

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

164-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays

7 January 2020

cites work

1 reference

12 December 2020

MHCPEP--a database of MHC-binding peptides: update 1995.

1 reference

12 December 2020

AN EXPERIMENTAL COMPARISON OF TRANSPLANTED TUMOR AND A TRANSPLANTED NORMAL TISSUE CAPABLE OF GROWTH

1 reference

12 December 2020

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

12 December 2020

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

1 reference

12 December 2020

An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia

1 reference

12 December 2020

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

12 December 2020

Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

1 reference

12 December 2020

A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

1 reference

12 December 2020

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

1 reference

12 December 2020

Epidermal cell presentation of tumor-associated antigens for induction of tolerance

1 reference

12 December 2020

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

12 December 2020

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

1 reference

12 December 2020

Monitoring of cancer patients undergoing active or passive immunotherapy.

1 reference

12 December 2020

Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.

1 reference

12 December 2020

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

12 December 2020

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

1 reference

12 December 2020

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

1 reference

12 December 2020

Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H‐2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

12 December 2020

Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine

1 reference

12 December 2020

The new vaccines: building viruses that elicit antitumor immunity.

1 reference

12 December 2020

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination

1 reference

12 December 2020

HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs

1 reference

12 December 2020

Transloading of tumor cells with foreign major histocompatibility complex class I peptide ligand: a novel general strategy for the generation of potent cancer vaccines

1 reference

12 December 2020

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

12 December 2020

Peptide binding to MHC class I molecules: implications for antigenic peptide prediction

1 reference

12 December 2020

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

12 December 2020

Tum- mutation P35B generates the MHC-binding site of a new antigenic peptide

1 reference

12 December 2020

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

1 reference

12 December 2020

Immune response against tumors.

1 reference

12 December 2020

Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells

1 reference

12 December 2020

The use of Epstein-Barr virus-transformed B lymphocyte cell lines in a peptide-reconstitution assay: identification of CEA-related HLA-A*0301-restricted potential cytotoxic T-lymphocyte epitopes

1 reference

12 December 2020

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)

1 reference

12 December 2020

Class I MHC-peptide interactions: structural requirements and functional implications

1 reference

12 December 2020

Experimental and clinical studies of cytokine gene-modified tumor cells

1 reference

12 December 2020

Detection and quantification of blood-derived CD8 T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

12 December 2020

Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells

1 reference

12 December 2020

Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

1 reference

12 December 2020

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

12 December 2020

Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8 cytotoxic T lymphocytes

1 reference

12 December 2020

Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes.

1 reference

12 December 2020

Tracking antigen-specific helper T cell responses

1 reference

12 December 2020

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

1 reference

12 December 2020

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8 cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

12 December 2020

MHC ligands and peptide motifs: first listing

1 reference

12 December 2020

Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen

1 reference

12 December 2020

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

1 reference

12 December 2020

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

12 December 2020

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

12 December 2020

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

12 December 2020

Recognition of BCR-ABL positive leukemic blasts by human CD4 T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide

1 reference

12 December 2020

Tumor cells expressing a recall antigen are powerful cancer vaccines

1 reference

12 December 2020

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

12 December 2020

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma

1 reference

12 December 2020

Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin

1 reference

12 December 2020

Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.

1 reference

12 December 2020

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3.

1 reference

12 December 2020

Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

1 reference

12 December 2020

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

12 December 2020

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

12 December 2020

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

12 December 2020

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

12 December 2020

Transloading of tumor antigen-derived peptides into antigen-presenting cells

1 reference

12 December 2020

Structure of peptides associated with class I and class II MHC molecules

1 reference

12 December 2020

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

12 December 2020

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance

1 reference

12 December 2020

HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.

1 reference

12 December 2020

Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display

1 reference

12 December 2020

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes

1 reference

12 December 2020

Human CD4 T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

12 December 2020

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

A reassessment of the role of B7-1 expression in tumor rejection.

1 reference

12 December 2020

Gene transfer as cancer therapy

1 reference

12 December 2020

Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype

1 reference

12 December 2020

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

12 December 2020

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

1 reference

12 December 2020

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease

1 reference

12 December 2020

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

12 December 2020

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

12 December 2020

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.

1 reference

12 December 2020

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

1 reference

12 December 2020

Tolerance, danger, and the extended family

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules.

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

1 reference

12 December 2020

Molecular cloning and characterization of the gene encoding mouse melanoma antigen by cDNA library transfection

1 reference

12 December 2020

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice

1 reference

12 December 2020

Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients

1 reference

12 December 2020

HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer

1 reference

12 December 2020

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

12 December 2020

Cell-free tumor antigen peptide-based cancer vaccines

1 reference

12 December 2020

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

12 December 2020

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

12 December 2020

A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent mu

1 reference

12 December 2020

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide

1 reference

12 December 2020

Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors

1 reference

12 December 2020

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

12 December 2020

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

12 December 2020

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

12 December 2020

Immunity to methylcholanthrene-induced sarcomas

1 reference

12 December 2020

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

1 reference

12 December 2020

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

12 December 2020

Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

1 reference

12 December 2020

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

1 reference

12 December 2020

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

12 December 2020

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

12 December 2020

Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific binding

1 reference

12 December 2020

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

12 December 2020

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability

1 reference

12 December 2020

HLA-DR1-restricted bcr-abl (b3a2)-specific CD4 T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates

1 reference

12 December 2020

Multiple tumour-specific antigens expressed on a single tumour cell

1 reference

12 December 2020

Adenovirus-enhanced receptor-mediated transferrinfection for the generation of tumor vaccines

1 reference

12 December 2020

Immunogenetics of human cell surface differentiation

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

1 reference

12 December 2020

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

12 December 2020

Targeting p53 as a general tumor antigen

1 reference

12 December 2020

Exposing the immunology of naked DNA vaccines

1 reference

12 December 2020

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

Specificities and functions of CD4 HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens

1 reference

12 December 2020

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

12 December 2020

Infection breaks T-cell tolerance.

1 reference

12 December 2020

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

12 December 2020

Human tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

12 December 2020

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

12 December 2020

T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides

1 reference

12 December 2020

Use of a skin test assay to determine tumor-specific CD8 T cell reactivity

1 reference

12 December 2020

Peptides naturally presented by MHC class I molecules

1 reference

12 December 2020

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

1 reference

12 December 2020

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

12 December 2020

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

12 December 2020

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1 reference

12 December 2020

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

12 December 2020

Antigen presentation in retroviral vector-mediated gene transfer in vivo

1 reference

12 December 2020

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

1 reference

12 December 2020

Cytokines, tumour-cell death and immunogenicity: a question of choice

1 reference

12 December 2020

A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state

1 reference

12 December 2020

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

1 reference

12 December 2020

Prognostic significance of hypopigmentation in malignant melanoma

1 reference

12 December 2020

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

12 December 2020

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

1 reference

12 December 2020

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02899917

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470726 AND SRC:MED&resulttype=core&format=json

7 January 2020

1 reference